Skip to navigation Skip to content

Treating SPMS


Modifying the Disease Course

More than a dozen disease modifying therapies are approved by the U.S. Food and Drug Administration (FDA) for use in relapsing forms of MS, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses).  Individuals who have been on one of these medications during the initial relapsing-remitting phase of the disease will likely continue on it unless it is no longer adequately controlling their disease activity.

Read more about these therapies in The MS Disease-Modifying Medications (.pdf).

Read more about starting, stopping or switching medications in the American Academy of Neurology Guideline: Disease Modifying Therapies for Adults with Multiple Sclerosis.

Managing symptoms

Regardless of the course of MS a person is experiencing, proactive symptom management is essential to maintaining comfort and productivity, and enhancing quality of life.


Rehabilitation specialists have an important role from the time of diagnosis helping people function optimally in spite of their MS, including enhancing mobility and promoting safety and independence.


The National MS Society is Here to Help

Newly Diagnosed
If you or somone close to you has recently been diagnosed, access our MS information and resources.

Start Here

Start Here
© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.